myeloma News
Most Popular myeloma Story
BMS inks $710M development deal with PDL
Bristol-Myers Squibb is paying $30 million upfront in a licensing deal for PDL BioPharma's... Read more...
Latest Headlines
- August 20, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


